Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2024-04-26 | Ms. Langer has significant experience and knowledge of the biopharmaceutical industry and deep connections within the biotechnology, start-up and venture capital ecosystems. Education: B.A. in Science & Technology Studies from Cornell University. |
Data sourced from SEC filings. Last updated: 2025-10-11